By Fineline Cube 
Gan & Lee Pharmaceuticals (SHA: 603087) announced the signing of Parcerias para o Desenvolvimento Produtivo (PDP) with Brazil’s Ministry of Health and its Brazilian partner Biomm (BVMF: BIOM3). This marks Gan & Lee as the first Chinese pharmaceutical company to enter Brazil’s PDP pharmaceutical project list.
Background on Collaboration
Gan & Lee Pharmaceuticals first partnered with Biomm in 2014. Together, they completed regulatory filing and successfully launched insulin glargine in the Brazilian market.
PDP Agreement Details
The PDP agreement aims to foster productive development partnerships, enhancing local pharmaceutical production capabilities and technological transfer in Brazil. Gan & Lee’s inclusion in the PDP project underscores its commitment to contributing to Brazil’s pharmaceutical sector growth and innovation.-Fineline Info & Tech